Clinical Trial Update: Remicade Infusion Management Program

View source ↗

Summary

This update reports completion of Janssen's Remicade infusion management program trial evaluating infliximab for Crohn's disease and rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Janssen Inc. | Conditions: Crohn Disease, Arthritis, Rheumatoid | Status: COMPLETED